M&A Deal Summary

Andrx Acquires Pfizer s New Drug Application

On November 25, 2003, Andrx acquired life science company Pfizer s New Drug Application from Pfizer for 35M USD

Acquisition Highlights
  • This is Andrx’s 1st transaction in the Life Science sector.
  • This is Andrx’s largest (disclosed) transaction.
  • This is Andrx’s 1st transaction in the United States.

M&A Deal Summary
Date 2003-11-25
Target Pfizer s New Drug Application
Sector Life Science
Buyer(s) Andrx
Sellers(s) Pfizer
Deal Type Divestiture
Deal Value 35M USD

Target

Pfizer s New Drug Application

United States
Pfizer's New Drug Application (NDA) for Cardura(R) XL, a sustained-release formulation of doxazosin mesylate, used to treat benign prostatic hyperplasia (BPH).

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Andrx

Davie, Florida, United States
Category Company
Founded 1992
Sector Life Science
Employees1,680
DESCRIPTION

Andrx Corporation is engaged in the formulation and commercialization of oral controlled-release pharmaceuticals utilizing its proprietary drug delivery technologies. In its ANDA program, Andrx is developing bio-equivalent or generic versions of selected high sales volume controlled-release brand name pharmaceuticals.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
Country (United States) 1 of 1
Year (2003) 1 of 1
Size (of disclosed) 1 of 1

Seller(S) 1

SELLER

Pfizer

New York, New York, United States
Category Company
Founded 1849
Sector Life Science
Employees8,300
Revenue 58.5B USD (2023)
DESCRIPTION
Pfizer office in Lake Forest, Illinois.
Pfizer office in Lake Forest, Illinois.

Pfizer is a global pharmaceutical company that is involved in the discovery, development, manufacture, and marketing of a wide range of healthcare products, including medicines and vaccines. The company's portfolio includes treatments across a broad spectrum of areas such as oncology, cardiology, neurology, and infectious diseases, among others. Pfizer was founded in 1849 and is based in New York, New York.

DEAL STATS #
Overall 4 of 18
Sector (Life Science) 1 of 13
Type (Divestiture) 4 of 15
Country (United States) 3 of 13
Year (2003) 1 of 1
Size (of disclosed) 9 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2003-04-16 Pharmacia

Peapack, New Jersey, United States

Pharmacia Corp. a pharmaceutical and biotechnological company.

Buy $60.0B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2003-12-21 Esperion Therapeutics

Plymouth, Michigan, United States

Development stage biotechnology company focused on cardiovascular drugs. Drug discovery and development company focused on therapies that prevent, treat and reverse cardiovascular and metabolic diseases.

Buy -
Mergr

Product

Company

Legal